Prospera Financial Services Inc Boosts Stock Position in CVS Health Corporation $CVS

Prospera Financial Services Inc boosted its position in shares of CVS Health Corporation (NYSE:CVS) by 7.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,728 shares of the pharmacy operator’s stock after acquiring an additional 1,728 shares during the quarter. Prospera Financial Services Inc’s holdings in CVS Health were worth $1,638,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of CVS. Hazlett Burt & Watson Inc. grew its holdings in shares of CVS Health by 10.9% in the second quarter. Hazlett Burt & Watson Inc. now owns 1,682 shares of the pharmacy operator’s stock valued at $117,000 after purchasing an additional 165 shares in the last quarter. Williams Financial LLC boosted its position in CVS Health by 2.5% in the 2nd quarter. Williams Financial LLC now owns 6,923 shares of the pharmacy operator’s stock valued at $478,000 after buying an additional 167 shares during the period. Hemington Wealth Management grew its stake in shares of CVS Health by 33.7% in the first quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator’s stock worth $46,000 after acquiring an additional 172 shares in the last quarter. Sumitomo Life Insurance Co. raised its stake in shares of CVS Health by 1.0% in the first quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator’s stock valued at $1,159,000 after acquiring an additional 174 shares in the last quarter. Finally, GW&K Investment Management LLC boosted its holdings in CVS Health by 39.4% in the first quarter. GW&K Investment Management LLC now owns 637 shares of the pharmacy operator’s stock valued at $43,000 after purchasing an additional 180 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director owned 22,156 shares in the company, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.22% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities research analysts have weighed in on CVS shares. Cowen restated a “buy” rating on shares of CVS Health in a report on Monday, August 4th. Leerink Partners upped their target price on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. UBS Group lifted their price target on shares of CVS Health from $79.00 to $96.00 and gave the stock a “buy” rating in a research note on Friday, October 24th. Raymond James Financial increased their price objective on shares of CVS Health from $75.00 to $90.00 in a research report on Friday, October 31st. Finally, Sanford C. Bernstein lifted their price objective on shares of CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a research report on Friday, September 5th. Two analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.45.

CVS Health Trading Up 2.8%

Shares of CVS Health stock opened at $79.73 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83. The company has a fifty day simple moving average of $77.36 and a 200-day simple moving average of $69.67. The stock has a market cap of $101.22 billion, a price-to-earnings ratio of 209.83, a PEG ratio of 0.87 and a beta of 0.60. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $85.15.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. During the same period in the previous year, the company earned $1.09 earnings per share. CVS Health’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is currently 700.00%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.